Literature DB >> 24391021

Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.

Myassa Arkam Dartell1, Vibeke Rasch, Thomas Iftner, Crispin Kahesa, Julius D Mwaiselage, Jette Junge, Anne Gernow, Sussi Funch Ejlersen, Christian Munk, Susanne Kruger Kjaer.   

Abstract

The aim of this cross sectional study was to assess type distribution of human papillomavirus (HPV) among HIV positive and HIV negative women who underwent cervical cancer screening, and to examine the ability of visual inspection with acetic acid (VIA), the standard detection method in Tanzania, and HPV-testing to detect cytologically diagnosed high grade lesions or cancer (HSIL+). Women from different areas in Tanzania were invited by public announcement to cervical cancer screening organized by Ocean Road Cancer Institute (Dar-es-Salaam). A total of 3,767 women were enrolled. Women underwent gynecological examination with collection of cervical cells for conventional cytological examination, and swab for HPV-DNA detection (Hybrid-Capture2) and genotyping (LiPAv2 test). Subsequently VIA was performed. The participants were also tested for HIV. HPV16, HPV52 and HPV18 were the three most common HR HPV types among women with HSIL+ cytology with prevalences of 42.9, 35.7 and 28.6%, respectively, in HIV positive women which was higher than among HIV negative women (30.2, 21.9 and 16.7%). A total of 4.5% of the women were VIA positive, and VIA showed a low sensitivity compared to HPV-testing for detection of HSIL+. The sensitivity of VIA varied with staff VIA experience, HIV status and age. Vaccines including HPV16, HPV52 and HPV18 will likely reduce the number of HSIL+ cases independently of HIV status. The frequency of HSIL+ was high among HIV positive women, emphasizing the importance of establishing a screening program which also reaches HIV positive women. Our results highlight the importance of continuous training of staff performing VIA, and also point to the need for other screening methods such as HPV-testing at low cost.
© 2014 UICC.

Entities:  

Keywords:  Africa; HIV; HPV testing; Tanzania; cervical cancer; pap smear; sensitivity; specificity; visual inspection with acetic acid

Mesh:

Substances:

Year:  2014        PMID: 24391021     DOI: 10.1002/ijc.28712

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Pragna Patel; Charles E Rose; Pamela Y Collins; Bernardo Nuche-Berenguer; Vikrant V Sahasrabuddhe; Emmanuel Peprah; Susan Vorkoper; Sonak D Pastakia; Dianne Rausch; Naomi S Levitt
Journal:  AIDS       Date:  2018-07-01       Impact factor: 4.177

2.  Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.

Authors:  Kathleen Lovgren; Amr S Soliman; Twalib Ngoma; Crispin Kahesa; Jane Meza
Journal:  Int J STD AIDS       Date:  2015-10-12       Impact factor: 1.359

3.  Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.

Authors:  Nicole G Campos; Philip E Castle; Thomas C Wright; Jane J Kim
Journal:  Int J Cancer       Date:  2015-05-21       Impact factor: 7.396

4.  Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.

Authors:  Agajie Likie Bogale; Tilahun Teklehaymanot; Getnet Mitike Kassie; Girmay Medhin; Jemal Haidar Ali; Nega Berhe Belay
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

5.  A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon.

Authors:  Philip E Castle; Rogers Ajeh; Anastase Dzudie; Ernestine Kendowo; Norbert Fuhngwa; Andre Gaetan Simo-Wambo; Denis Nsame; Enow Orock; Tiffany M Hebert; Amanda J Pierz; Daniel Murokora; Kathryn Anastos; Adebola Adedimeji
Journal:  Infect Agent Cancer       Date:  2020-07-11       Impact factor: 2.965

6.  Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.

Authors:  Megan J Huchko; Jennifer Sneden; George Sawaya; Karen Smith-McCune; May Maloba; Naila Abdulrahim; Elizabeth A Bukusi; Craig R Cohen
Journal:  Int J Cancer       Date:  2014-06-10       Impact factor: 7.396

Review 7.  A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa.

Authors:  Manuela Viviano; Pierre DeBeaudrap; Pierre-Marie Tebeu; Jovanny T Fouogue; Pierre Vassilakos; Patrick Petignat
Journal:  Int J Womens Health       Date:  2017-02-02

Review 8.  Cervical cancer control in HIV-infected women: Past, present and future.

Authors:  Rahel G Ghebre; Surbhi Grover; Melody J Xu; Linus T Chuang; Hannah Simonds
Journal:  Gynecol Oncol Rep       Date:  2017-07-21

9.  Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women (Connected2Care): study protocol for a randomised controlled trial.

Authors:  Ditte S Linde; Marianne S Andersen; Julius D Mwaiselage; Rachel Manongi; Susanne K Kjaer; Vibeke Rasch
Journal:  Trials       Date:  2017-11-21       Impact factor: 2.279

Review 10.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.